Videos
Understanding Indications, Tailoring Therapy Options for CLL Patients
05/18/2020
Benyam Muluneh, PharmD, assistant professor, UNC Eshelman School of Pharmacy, and Katie Buhlinger, PharmD, CPP, clinical pharmacist practitioner, UNC Medical Center, discuss the benefits and complications associated with ibrutinib treatment for patients with CLL.
Current Issue
October/November/December Volume 21, Issue 4, First Report Managed CareWhat's Trending?
Subscribe to our eNewsletters!
First Report Managed Care Newsletter